Influence of oral conditions on colonization by highly toxigenic Staphylococcus aureus strains

Oral Diseases

Volumn 18, Issue 4, 2012, Pages 402-409

  Passariello, C ^a   Puttini, M ^b   Iebba, V ^a   Pera, P ^c   Gigola, P ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Fixed prosthesis; Nasal carriage; Oral carriage; Periodontitis; Staphylococcus aureus

Indexed keywords

EXOTOXIN;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHEEK; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; GINGIVA; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUTH CAVITY; MOUTH DISEASE; NONHUMAN; PERIODONTIC DEVICE; PERIODONTITIS; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS NASAL CARRIAGE; STAPHYLOCOCCUS AUREUS ORAL CARRIAGE;

ADULT; ALVEOLAR BONE LOSS; BACTERIAL LOAD; BACTERIAL PROCESSES; BACTERIAL TOXINS; CHEEK; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DENTAL PROSTHESIS; EXOTOXINS; FEMALE; GENETIC VARIATION; GENOTYPE; GINGIVA; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOUTH; MOUTH MUCOSA; NOSE; PERIODONTAL INDEX; PERIODONTAL POCKET; PHENOTYPE; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84859109385     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01889.x     Document Type: Article

References (51)

1. Armstrong-Esther CA, Smith JE (1976). Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 3: 221-227.
2. Bohach GA, Foster TJ(1999). Staphylococcus aureus exotoxins. In: Fischetti VA, Novick RP, Ferretti JJ, Rood JI, eds. Gram positive bacterial pathogens. American Society for Microbiology: Washington, D.C., pp. 367-378.
3. Brakstad OG, Aasbakk K, Maeland JA (1992). Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 30: 1654-1660.
4. Bukowski M, Wladyka B, Dubin G (2010). Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) 2: 1148-1165.
5. Buonavoglia A, Latronico F, Greco MF et al (2010). Methicillin-resistant staphylococci carriage in the oral cavity: a study conducted in Bari (Italy). Oral Dis 16: 465-468.
6. Chesney PJ, Bergdoll MS, Davis JP, Vergeront JM (1984). The disease spectrum, epidemiology, and etiology of toxic-shock syndrome. Annu Rev Microbiol 38: 315-338.
7. Clinical and Laboratory Standards Institute (2009). Performance standard for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute: Wayne, PA.
8. Cole AM, Tahk S, Oren A et al (2001). Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 8: 1064-1069.
9. Cuesta AI, Jewtuchowicz V, Brusca MI, Nastri ML, Rosa AC (2010). Prevalence of Staphylococcus spp and Candida spp in the oral cavity and periodontal pockets of periodontal disease patients. Acta Odontol Latinoam 23: 20-26.
10. von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001). Nasal carriage as a source of Staphylococcus aureus bacteremia. New Engl J Med 344: 11-16.
11. El Attar MM, Zaghloup MZ, Elmenoufr HS (2010). Role of periodontitis in hospital-acquired pneumonia. East Mediterr Health J 16: 563-569.
12. Eriksen NH, Espersen F, Rosdahl VT, Jensen K (1995). Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect 115: 51-60.
13. Fedtke I, Gotz F, Peschel A (2004). Bacterial evasion of innate host defenses - the Staphylococcus aureus lesson. Int J Med Microbiol 294: 189-194.
14. Felton DA, Kanoy BE, Bayne SC, Wirthman GP (1991). Effect of in vivo crown margin discrepancies on periodontal health. J Prosthet Dent 65: 357-364.
15. Feng Y, Chen CJ, Su LH, Hu S, Yu J, Chiu CH (2008). Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol Rev 32: 23-37.
16. Foster TJ, Höök M (1998). Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 6: 484-488.
17. Fritschi BZ, Albert-Kiszely A, Persson GR (2008). Staphylococcus aureus and other bacteria in untreated periodontitis. J Dent Res 87: 589-593.
18. Fuda CC, Fisher JF, Mobashery S (2005). Beta lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell Mol Life Sci 62: 2617-2633.
19. Garlet GP (2010). Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 89: 1349-1363.
20. Goodyear CS, Silverman GJ (2003). Death by a B cell superantigen: in vivo VH-targeted apoptotic supraclonal B cell deletion by a staphylococcal toxin. J Exp Med 197: 1125-1139.
21. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E (2006). Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368: 874-885.
22. Hannig C, Hannig M (2009). The oral cavity - a key system to understand substratum-dependent bioadhesion on solid surfaces in man. Clin Oral Investig 13: 123-139.
23. Hauser AR, Jain M, Bar-Meir M, McColley SA (2011). Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 24: 29-70.
24. Herwaldt LA, Cullen JJ, French P et al (2004). Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 25: 481-484.
25. Hiratsuka K, Hayakawa M, Kiyama-Kishikawa M, Sasaki Y, Hirai T, Abiko Y (2008). Role of the hemin-binding protein 35 (HBP35) of Porphyromonas gingivalis in coaggregation. Microb Pathog 44: 320-328.
26. Kamaguchi A, Nakayama K, Ichiyama S et al (2003). Effect of Porphyromonas gingivalis vesicles on coaggregation of Staphylococcus aureus to oral microorganisms. Curr Microbiol 47: 485-491.
27. Kloos WE, Jorgensen JH(1985). Staphylococci. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy JH, eds. Manual of clinical microbiology, 4th edn. American Society for Microbiology: Washington DC, pp. 143-153.
28. Kluytmans J, van Belkum A, Verbrugh H (1997). Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10: 505-520.
29. Kuehn MJ, Kesty NC (2005). Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19: 2645-2655.
30. Lindsay JA, Moore CE, Day NP et al (2006). Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface associated and regulatory genes. J Bacteriol 188: 669-676.
31. Lozano C, Gómez-Sanz E, Benito D, Aspiroz C, Zarazaga M, Torres C(2011).Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains. Int J Med Microbiol 301: 500-505.
32. Maxwell JG, Ford CR, Peterson DE, Mitchell CR (1969). Long-term study of nasal staphylococci among hospital personnel. Am J Surg 118: 849-854.
33. Nouwen J, Boelens H, van Belkum A, Verbrugh H (2004). Human factor in Staphylococcus aureus nasal carriage. Infect Immun 72: 6685-6688.
34. Nouwen JL, Fieren MW, Snijders S, Verbrugh HA, van Belkum A (2005). Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int 67: 1084-1092.
35. Passariello C, Thaller MC, Selan L, Berlutti F, de Luca M, Renzini G (1991). Periodontal regeneration procedures may induce colonization by glycocalyx-producing bacteria. Med Microbiol Immunol 180: 67-72.
36. Pye AD, Lockhart DE, Dawson MP, Murray CA, Smith AJ (2009). A review of dental implants and infection. J Hosp Infect 72: 104-110.
37. Ridley M (1959). Perineal carriage of Staphylococcus aureus. Br Med J 34: 270-273.
38. Scazzocchio F, Aquilanti L, Tabacchini C, Iebba V, Passariello C (2010). Microbiological and molecular characterization of nosocomial and community Staphylococcus aureus isolates. Epidemiol Infect 139: 613-622.
39. Sivaraman K, Cole AM (2009). Pathogenesis gene families in the common minimal genome of Staphylococcus aureus are hypervariable. FEBS Lett 583: 1304-1308.
40. Sivaraman K, Venkataraman N, Cole AM (2009). Staphylococcus aureus nasal carriage and its contributing factors. Future Microbiol 4: 999-1008.
41. Small H, Casey AL, Elliott TS, Rollason J, Hilton AC, Ball S (2007). The oral cavity - an overlooked site for MRSA screening and subsequent decolonisation therapy? J Infect 55: 378-383.
42. Smith AJ, Jackson MS, Bagg J (2001). The ecology of Staphylococcus species in the oral cavity. J Med Microbiol 50: 940-946.
43. Smith AJ, Brewer A, Kirkpatrick P et al (2003a). Staphylococcal species in the oral cavity from patients in a regional burns unit. J Hosp Infect 55: 184-189.
44. Smith AJ, Robertson D, Tang MK, Jackson MS, MacKenzie D, Bagg J (2003b). Staphylococcus aureus in the oral cavity: a three-year retrospective analysis of clinical laboratory data. Br Dent J 195: 701-703.
45. Solberg CO (1965). A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimations. Acta Med Scand Suppl 436: 1-96.
46. Tada A, Senpuku H, Motozawa Y, Yoshihara A, Hanada N, Tanzawa H (2006). Association between commensal bacteria and opportunistic pathogens in the dental plaque of elderly individuals. Clin Microbiol Infect 12: 776-781.
47. VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA (1999). Follow-up of Staphylococcus aureus nasal carriage after 8years: redefining the persistent carrier state. J Clin Microbiol 37: 3133-3140.
48. Wertheim HF, Melles DC, Vos MC et al (2005). The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5: 751-762.
49. White A (1963). Increased infection rates in heavy nasal carriers of coagulase-positive staphylococci. Antimicrob Agents Chemother 161: 667-670.
50. Williams REO (1963). Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev 27: 56-71.
51. Zuanazzi D, Souto R, Mattos MB et al (2010). Prevalence of potential bacterial respiratory pathogens in the oral cavity of hospitalised individuals. Arch Oral Biol 55: 21-28.